Medtronic Global Holdings SCA EO-Notes 2020(20/28)
- BID
94.07
- ASK
94.151
- 500,000 Nom.500,000 Nom.
- 07/27, 18:00:00 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
3.18
Yield spread Bundesanleihe
0.4038
Tradable for private investors
No
Minimum amount tradeable unit
100,000.00
Maturity
15/10/2028
Interest Rate
0.375 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 94.087 G / 3.18 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 05:06:14 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 0.4038 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 94.11 | 93.988 |
| PREV. DAY'S PRICE | 93.977 | (07/24) |
| CHANGE DAY BEFORE | +0.11 | 0.12 % |
| 52 WEEK HIGH / LOW | 94.476 (02/11) | 92.379 (03/27) |
Master Data
| WKN | A28293 |
| ISIN | XS2238789460 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Medtronic Global Holdings SCA |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 0.375 % |
| INTEREST RUN FROM | 29/09/2020 |
| NEXT INTEREST PAYMENT | 15/10/2026 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.295 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 1.00 Bil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 100,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 15/10/2028 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Make Whole Call Option. Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.